- Home
- BIOA vs PESI Comparison
BIOA vs PESI Comparison
Compare BIOA & PESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOA
- PESI
- Stock Information
- Founded
- BIOA 2015
- PESI 1990
- Country
- BIOA United States
- PESI United States
- Employees
- BIOA N/A
- PESI N/A
- Industry
- BIOA Biotechnology: Pharmaceutical Preparations
- PESI Environmental Services
- Sector
- BIOA Health Care
- PESI Industrials
- Exchange
- BIOA Nasdaq
- PESI Nasdaq
- Market Cap
- BIOA 144.1M
- PESI 153.1M
- IPO Year
- BIOA 2024
- PESI 1992
- Fundamental
- Price
- BIOA $4.11
- PESI $9.50
- Analyst Decision
- BIOA Hold
- PESI Strong Buy
- Analyst Count
- BIOA 4
- PESI 1
- Target Price
- BIOA $5.67
- PESI $18.00
- AVG Volume (30 Days)
- BIOA 246.5K
- PESI 181.7K
- Earning Date
- BIOA 05-06-2025
- PESI 05-08-2025
- Dividend Yield
- BIOA N/A
- PESI N/A
- EPS Growth
- BIOA N/A
- PESI N/A
- EPS
- BIOA N/A
- PESI N/A
- Revenue
- BIOA $1,451,000.00
- PESI $59,419,000.00
- Revenue This Year
- BIOA N/A
- PESI $38.20
- Revenue Next Year
- BIOA N/A
- PESI $98.88
- P/E Ratio
- BIOA N/A
- PESI N/A
- Revenue Growth
- BIOA N/A
- PESI N/A
- 52 Week Low
- BIOA $2.88
- PESI $6.25
- 52 Week High
- BIOA $26.62
- PESI $16.25
- Technical
- Relative Strength Index (RSI)
- BIOA N/A
- PESI 71.12
- Support Level
- BIOA N/A
- PESI $8.50
- Resistance Level
- BIOA N/A
- PESI $9.49
- Average True Range (ATR)
- BIOA 0.00
- PESI 0.57
- MACD
- BIOA 0.00
- PESI 0.12
- Stochastic Oscillator
- BIOA 0.00
- PESI 87.44
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.